Influence of aspirin on inflammatory markers in patients after acute myocardial infarction
Authors:
- 1 October 2003
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 92 (7) , 843-845
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Warfarin, Aspirin, or Both after Myocardial InfarctionNew England Journal of Medicine, 2002
- Elevation of Tumor Necrosis Factor-α and Increased Risk of Recurrent Coronary Events After Myocardial InfarctionCirculation, 2000
- Interleukin-10 Blocks Atherosclerotic Events In Vitro and In VivoArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Increased Proinflammatory Cytokines in Patients With Chronic Stable Angina and Their Reduction By AspirinCirculation, 1999
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- Inflammation, Pravastatin, and the Risk of Coronary Events After Myocardial Infarction in Patients With Average Cholesterol LevelsCirculation, 1998
- The Effect of Different Antithrombotic Regimens on Platelet Aggregation After Myocardial InfarctionScandinavian Cardiovascular Journal, 1998
- Aspirin Inhibits Nuclear Factor–κB Mobilization and Monocyte Adhesion in Stimulated Human Endothelial CellsCirculation, 1995
- Inhibition of NF-κB by Sodium Salicylate and AspirinScience, 1994
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993